Zhejiang Aoliding Biotechnology

Zhejiang Aoliding Biotechnology, also known as Oriding Biotechnology, is a life sciences company specializing in high-throughput single-cell sequencing and spatial transcriptomics. The company develops and manufactures automated platforms, such as the Aoli-1000, which utilizes microfluidic droplet technology to enable large-scale cellular analysis. Their product portfolio includes comprehensive reagent kits and bioinformatics pipelines designed for applications in oncology, immunology, and precision medicine. By integrating hardware, chemistry, and software, Aoliding provides end-to-end solutions that facilitate the exploration of complex biological systems at single-cell resolution. The company aims to provide accessible, high-quality genomic tools to the global research community.